Dhampur Bio Organics Reports Robust Q2 FY27 Financial and Operational Performance
Dhampur Bio Organics Ltd · Investor Presentation · 15 Nov 2026, 3:45 am
Dhampur Bio Organics Reports Robust Q2 FY27 Financial and Operational Performance Dhampur Bio Organics reported revenue net of excise of ₹665.5 Cr in Q2 FY27, up 24% YoY, driven by higher sugar realisations and volume growth in Country Liquor. EBITDA jumped 364% YoY to ₹60.0 Cr with margins expanding 661 bps to 9.02%. The company turned profitable with a PAT of ₹26.6 Cr versus a net loss of ₹15.5 Cr in Q2 FY26. As of 30th Sep'26, long-term debt-to-equity stood at 0.10x with surplus funds of ₹116.4 Cr.
Original exchange filing (PDF)
More announcements from Dhampur Bio Organics Ltd
- Appointment of Cost Auditor of the Company to fill casual vacancy for the FY 2026-27. · 14 Nov 2026
- Audited Financial Results for the quarter and half year ended September 30, 2026 · 14 Nov 2026
- Dhampur Bio Organics Limited has submitted to the Exchange, the audited financial results for the period ended September 30, 2026 and approved the buyback subject to the approval of shareholders. · 14 Nov 2026
- Outcome of Board Meeting held on November 14, 2026 · 14 Nov 2026
- Intimation of Grant of Stock options pursuant to DBO Employee Stock Option Scheme 2025 as approved by the Nomination and Remuneration Committee. · 12 Nov 2026
- Dhampur Bio Organics Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Audited Financial results of the Company for the period ended September 2026 and Buyback/Other business. · 14 Nov 2026
- Dhampur Bio Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. Audited Standalone .... · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and consider buy back of equity shares of the company and other business matters · 14 Nov 2026
